Globus Medical (GMED) to Release Earnings on Thursday

Globus Medical (NYSE:GMED) is projected to announce its earnings results after the market closes on Thursday, February 20th. Analysts expect the company to announce earnings of $0.74 per share and revenue of $646.19 million for the quarter. Investors interested in participating in the company’s conference call can do so using this link.

Globus Medical Trading Up 0.9 %

NYSE:GMED opened at $84.72 on Wednesday. The company has a market cap of $11.54 billion, a PE ratio of 126.45, a P/E/G ratio of 1.68 and a beta of 1.19. Globus Medical has a twelve month low of $49.33 and a twelve month high of $94.93. The company’s 50 day moving average is $86.67 and its two-hundred day moving average is $78.76.

Analysts Set New Price Targets

Several analysts have weighed in on GMED shares. Stifel Nicolaus boosted their target price on shares of Globus Medical from $80.00 to $92.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th. Bank of America upgraded shares of Globus Medical from an “underperform” rating to a “neutral” rating and lifted their price objective for the company from $80.00 to $97.00 in a research note on Thursday, January 9th. Wells Fargo & Company lifted their price objective on shares of Globus Medical from $88.00 to $95.00 and gave the company an “overweight” rating in a research note on Wednesday, December 11th. Canaccord Genuity Group lifted their price objective on shares of Globus Medical from $92.00 to $101.00 and gave the company a “buy” rating in a research note on Friday, January 10th. Finally, Piper Sandler lifted their price objective on shares of Globus Medical from $80.00 to $100.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. Three equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, Globus Medical currently has a consensus rating of “Moderate Buy” and a consensus target price of $96.91.

Insider Activity at Globus Medical

In other Globus Medical news, SVP Kelly Huller sold 2,500 shares of the company’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $87.00, for a total transaction of $217,500.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Keith W. Pfeil sold 14,167 shares of the company’s stock in a transaction on Friday, January 10th. The stock was sold at an average price of $88.29, for a total transaction of $1,250,804.43. The disclosure for this sale can be found here. Company insiders own 18.54% of the company’s stock.

Globus Medical Company Profile

Globus Medical, Inc, a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.